Omega Funds

Biotechnology · Venture Capital
161investments
42exits
$309Mraised by its portfolio in 12 months
7,466open roles in its portfolio

Overview

Omega Funds is a life sciences venture capital firm investing in exceptional founders, impactful products and platforms. It backs biotechnology and medical technology companies across multiple therapeutic areas, from company creation to later-stage private rounds. The firm was founded in 2004 and is headquartered in Boston, Massachusetts, with a presence in Europe as well.

Key facts

These are the key facts about Omega Funds on Alion as of Nov 13, 2026. Omega Funds is headquartered in Boston, United States. It was founded in 2004.

Headquarters
Boston, United StatesAlion company profile, updated Sep 16, 2026
Founded
2004Alion company profile, updated Sep 16, 2026
Employees
10+Alion company profile, an estimated range

Investor profile

Venture capital
Investments
161
23 of them startups
Hiring now
34
7,466 open roles
Rounds in 12 months
5
$309M raised
Exits
42
Focusshare of its companies
Health Care 84%Biotechnology 30%Food & Beverages 3%Manufacturing 3%Farming & Agriculture 3%Financial Services 2%Design & Creative 2%Software 2%
Where its companies are
United States 19%Germany 3%Switzerland 1%France 1%Ireland 1%United Kingdom 1%
Stage of its companies
Series B 45%Series C and later 38%Pre-seed & seed 14%Series A 3%
Sources: its portfolio page, read Nov 8; 1 rounds in the press that name it

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Boston United States
HQ
10-50 est. staff

How to cite this page

Alion, "Omega Funds: key facts", as of Nov 13, 2026. https://alion.io/company/omega-funds

These figures are published under a free licence. You may reuse them, including commercially, as long as you credit Alion and link back to this page. CC BY-SA 4.0